TCF12 Deficiency Impairs the Proliferation of Glioblastoma Tumor Cells and Improves Survival
Isocitrate dehydrogenase (IDH)-wild-type glioblastoma (GBM) is the most common and aggressive primary brain tumor which carries a very poor overall prognosis and is universally fatal. Understanding the transcriptional regulation of the proliferation of GBM tumor cells is critical for developing nove...
Main Authors: | Yunong Pang, Sichang Zhou, Paul Zumbo, Doron Betel, Babacar Cisse |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/7/2033 |
Similar Items
-
The river blindness drug Ivermectin and related macrocyclic lactones inhibit WNT‐TCF pathway responses in human cancer
by: Alice Melotti, et al.
Published: (2014-10-01) -
Tumor xenograft modeling identifies an association between TCF4 loss and breast cancer chemoresistance
by: Gorka Ruiz de Garibay, et al.
Published: (2018-05-01) -
TCF3 Regulates the Proliferation and Apoptosis of Human Spermatogonial Stem Cells by Targeting PODXL
by: Dai Zhou, et al.
Published: (2021-08-01) -
Two novel variants in the TCF12 gene identified in cases with craniosynostosis
by: Goumenos A, et al.
Published: (2019-02-01) -
Xenotransplantation of Human glioblastoma in Zebrafish larvae: in vivo imaging and proliferation assessment
by: Luis A. Vargas-Patron, et al.
Published: (2019-05-01)